跳至主要内容
临床试验/DRKS00022844
DRKS00022844尚未招募4 期

The Effects of Maternal Domperidone Intake on the Growth of Their Preterm Neonates in Kabul City: A Randomized Clinical Trial - EMDIGP

Kabul University of Medical Science0 个研究点目标入组 90 人开始时间: 2021年2月9日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
4 Days 至 35 Years(—)
性别
All

入选标准

  • The mothers aged less than 35y old with preterm delivery and insufficient breast milk (the amount of expressed breast milk become less than the appropriate requirement of babies or the mothers report they have insufficient breast milk) together with their preterm neonates fulfill one of the following criteria will be enrolled in the study.
  • 1-Gestational age of 34 weeks or less.
  • 2-Weight of less than 2000g.

排除标准

  • The mothers who have abnormal liver function test, mastitis, twin’s delivery, undergone mastectomy, BMI less than 18, conduction abnormalities on ECG and taking GYP3A4 inhibitors (macrolide, calcium channel blockers, ketoconazole, fluconazole, cimetidine), antipsychotic, antidepressant, tranquilizers, antacids, bromocriptin, and metoclopramide would be excluded from the study. The Neonates have visible or physically detected malformation, birth weight less than 1000g, seriously ill condition, taking probiotic, and the parent who declined consent; are the other exclusion criteria.

研究者

发起方
Kabul University of Medical Science

相似试验

The Effects of Maternal Domperidone Intake on the... | 临床试验